MarketCap
Facebook
X
TelegramAnnual report 2026
added 03-20-2026
Veeva Systems DSO Ratio 2011-2026 | VEEV
Annual DSO Ratio Veeva Systems
| 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 130 | 124 | 120 | 113 | 118 | 119 | 140 | 136 | 124 | 123 | 129 | 108 | 104 | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 140 | 104 | 122 |
Quarterly DSO Ratio Veeva Systems
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 41.4 | 52.9 | 45 | - | - | - | 47 | 61.2 | 90.5 | - | 45.9 | 54.9 | 80.8 | 89.2 | 47.4 | 54.7 | 68.6 | 83.9 | 48.9 | 58.9 | 73 | 82.5 | 42.6 | 52.9 | 72.5 | 77.2 | 41 | 58 | 78.8 | 78.7 | 44.7 | 57.2 | 73.7 | 84 | 49.4 | 59.3 | 66.5 | 88.1 | 61.1 | 64.3 | 65.3 | 75.3 | 58.3 | 74.2 | 67.2 | 98.3 | 40.3 | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 98.3 | 40.3 | 64.1 |
DSO Ratio of other stocks in the Health information services industry
| Issuer | DSO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Accolade
ACCD
|
9.76 | - | 0.29 % | $ 206 M |  USA |
 |
Change Healthcare
CHNG
|
87 | - | - | $ 9.03 B | USA |
 |
Cerner Corporation
CERN
|
73.8 | - | - | $ 27.9 B | USA |
 |
American Well Corporation
AMWL
|
89 | $ 5.63 | -2.26 % | $ 90.3 M | USA |
 |
Computer Programs and Systems
CPSI
|
59.7 | - | 4.4 % | $ 133 M | USA |
 |
Covetrus
CVET
|
39.4 | - | - | $ 2.94 B | USA |
 |
Castlight Health, Inc.
CSLT
|
79 | - | -7.28 % | $ 227 M | USA |
 |
HMS Holdings Corp.
HMSY
|
144 | - | - | $ 3.29 B | USA |
 |
Inovalon Holdings, Inc.
INOV
|
94.4 | - | - | $ 6.37 B | USA |
 |
HealthStream
HSTM
|
40.4 | $ 21.23 | 1.24 % | $ 645 M | USA |
 |
iCAD
ICAD
|
127 | - | - | $ 102 M | USA |
 |
Evolent Health
EVH
|
210 | $ 2.27 | 0.89 % | $ 213 M | USA |
 |
NextGen Healthcare
NXGN
|
51.6 | - | - | $ 1.6 B | USA |
 |
Omnicell
OMCL
|
83.4 | $ 34.94 | 1.39 % | $ 1.61 B | USA |
 |
1Life Healthcare
ONEM
|
50.2 | - | - | $ 3.37 B | USA |
 |
OptimizeRx Corporation
OPRX
|
149 | $ 7.18 | 5.9 % | $ 123 M | USA |
 |
MTBC
MTBC
|
42.2 | - | -0.58 % | $ 51.7 M | USA |
 |
Phreesia
PHR
|
59.5 | $ 11.28 | - | $ 615 M | USA |
 |
Premier
PINC
|
139 | - | - | $ 2.33 B | USA |
 |
GoodRx Holdings
GDRX
|
66.7 | $ 2.06 | 0.98 % | $ 795 M | USA |
 |
Schrödinger
SDGR
|
227 | $ 11.4 | -1.47 % | $ 837 M | USA |
 |
Signify Health
SGFY
|
272 | - | -0.02 % | $ 7.21 B | USA |
 |
R1 RCM
RCM
|
27.5 | - | - | $ 3.81 B | USA |
 |
Akerna Corp.
KERN
|
7.62 | - | - | $ 161 M | USA |
 |
Zhongchao
ZCMD
|
116 | $ 1.8 | -0.55 % | $ 9.37 M |  China |
 |
Streamline Health Solutions
STRM
|
59.4 | - | - | $ 21.4 M | USA |
 |
Teladoc Health
TDOC
|
29.4 | $ 5.57 | 2.77 % | $ 982 M | USA |
 |
Allscripts Healthcare Solutions
MDRX
|
81.9 | - | -10.39 % | $ 886 M | USA |
 |
10x Genomics
TXG
|
64.6 | $ 20.91 | 5.55 % | $ 2.45 B | USA |
 |
Health Catalyst
HCAT
|
68.2 | $ 1.1 | 0.46 % | $ 76.9 M | USA |
 |
NantHealth
NH
|
32 | - | -46.64 % | $ 10.4 M | USA |
 |
HealthEquity
HQY
|
33.6 | $ 82.47 | 0.45 % | $ 7.1 B | USA |
 |
SCWorx Corp.
WORX
|
41.4 | $ 0.13 | 1.5 % | $ 190 K | USA |
 |
Tabula Rasa HealthCare
TRHC
|
24.8 | - | - | $ 255 M | USA |
 |
Progyny
PGNY
|
292 | $ 17.75 | -1.66 % | $ 1.52 B | USA |
 |
So-Young International
SY
|
-6.34 K | $ 3.19 | 9.62 % | $ 253 M | China |